XML 172 R83.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Reporting Disclosure [Text Block]: Schedule of Segment Reporting Information, by Segment (Tables)
12 Months Ended
Dec. 31, 2019
Tables/Schedules  
Schedule of Segment Reporting Information, by Segment

 

 

 

2019

 

 

2018

Revenues:

 

 

 

 

Specialty Health

 

$

193,823  

 

$

202,938  

Group disability, life, DBL and PFL

 

 

169,038  

 

 

144,629  

Individual life, annuities and other (A)

 

 

1,669  

 

 

1,932  

Medical Stop-Loss (A)

 

 

 

 

 

40  

Corporate

 

 

5,853  

 

 

2,269  

 

 

370,389  

 

 

351,808  

Net investment gains (losses)

 

 

4,705  

 

 

(1,033) 

Net impairment losses recognized in earnings

 

 

(646) 

 

 

 

 

 

 

 

 

 

 

   Total revenues

 

$

374,448  

 

$

350,775  

 

 

 

 

 

 

 

Income before income taxes

 

 

 

 

 

 

Specialty Health (B)

 

$

7,757  

 

$

28,735  

Group disability, life, DBL and PFL

 

 

21,809  

 

 

18,863  

Individual life, annuities and other  (A) (C)

 

 

(1,433) 

 

 

(436) 

Medical Stop-Loss (A)

 

 

304  

 

 

177  

Corporate

 

 

(7,148) 

 

 

(8,765) 

 

 

21,289  

 

 

38,574  

Net investment gains (losses)

 

 

4,705  

 

 

(1,033) 

Net impairment losses recognized in earnings

 

 

(646) 

 

 

 

 

 

 

 

 

 

 

   Income before income taxes

 

$

25,348  

 

$

37,541  

 

(A)Substantially all of the business in the segment is coinsured. Activity in this segment primarily reflects income or expenses related to the coinsurance and the run-off of any remaining blocks that were not coinsured. 

 

(B)In 2019, the Specialty Health segment includes: (i) an other-than-temporary impairment loss of $3,712,000, a provision for losses on a note receivable of $1,773,000, and equity losses of $2,713,000, all in connection with the Company’s equity investment in Ebix Health Exchange (see Note 6 for more information); (ii) a provision for losses of $2,412,000 on other notes and receivables (primarily a note receivable from an unaffiliated lead generation company); and (iii) significant costs associated with hiring, training and licensing a significant number of new agents, as well as costs for system development in our marketing and administrative companies. 

 

(C)The Individual life, annuities and other segment includes amortization of deferred charges in connection with the assumptions of certain ceded life and annuity policies amounting to $788,000 and $888,000 for the years ended December 31, 2019 and 2018, respectively. 

 

 

 

 

 

December 31,

 

 

 

2019

 

 

2018

IDENTIFIABLE ASSETS AT YEAR END

 

 

 

 

Specialty Health

 

$

223,679 

 

$

225,315 

Group disability, life, DBL and PFL

 

 

324,139 

 

 

308,183 

Individual life, annuities and other

 

 

348,305 

 

 

348,036 

Medical Stop-Loss

 

 

13,161 

 

 

23,983 

Corporate

 

 

145,019 

 

 

131,999 

 

 

 

 

 

 

 

 

 

$

1,054,303 

 

$

1,037,516